Clinical Trial Categories
  • Age & Physical Activity (1)
  • Alzheimer's Disease (7)
  • Arthritis (3)
  • Asthma (1)
  • Cancer - Bladder (1)
  • Cancer - Brain & CNS (16)
  • Cancer - Breast (8)
  • Cancer - Colon/Colorectal (2)
  • Cancer - Digestive System (2)
  • Cancer - Female Reproductive (8)
  • Cancer - Gastric (1)
  • Cancer - Kidney (2)
  • Cancer - Leukemia (6)
  • Cancer - Liver (1)
  • Cancer - Lung (3)
  • Cancer - Lymphoma (27)
  • Cancer - Melanoma (15)
  • Cancer - Mesothelioma (2)
  • Cancer - Myeloma (10)
  • Cancer - Other (5)
  • Cancer - Ovarian (2)
  • Cancer - Pancreas (2)
  • Cancer - Peritoneal (5)
  • Cancer - Prostate (12)
  • Cancer - Sarcoma (1)
  • Cancer - Stomach (1)
  • Cancer - Testicular (1)
  • Cancer - Tissue (6)
  • Crohn's Disease (3)
  • Dermatitis (2)
  • Dermatomyositis (1)
  • Healthy (6)
  • Hepatitis C (2)
  • HIV (4)
  • HPV (1)
  • Hypercholesterolemia (1)
  • Immune Disease - Autoimmune (9)
  • Immune Disease - Primary (2)
  • Immune Disease - Secondary (6)
  • Infectious Disease (2)
  • Inflammatory Disease (3)
  • Kidney Transplant (1)
  • Liver Disease (2)
  • Lupus Erythematosus (3)
  • Multiple Sclerosis (3)
  • Neurodegenerative (1)
  • OX40 (1)
  • Parkinson's Disease (1)
  • Pediatric (3)
  • Transplant (2)

KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Friday
Apr012011

NCT01329354

Rituximab and Autologous Effector Lymphocytes in Non-Hodgkins Follicular Lymphoma in Response to First Line Chemotherapy

Conditions: Non-Hodgkin Lymphoma
Sponsors: Clinica Universidad de Navarra, Universidad de Navarra
Phase: II 

Date: DateApril 1, 2011
Categories CategoryCancer - Lymphoma
Tags ,
Sunday
Mar132011

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety and Immunogenicity of Neovacs’ TNFα-Kinoid in Adult Subjects with Crohn’s Disease

Conditions: Crohn’s Disease
Sponsors: Neovacs SA
Phase II

Date: DateMarch 13, 2011
Categories CategoryCrohn's Disease, CategoryInflammatory Disease
Tags , ,
Friday
Dec172010

NCT01291810

Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients

Conditions: Crohn's Disease
Sponsors: Neovacs
Phase II

Date: DateDecember 17, 2010
Categories CategoryCrohn's Disease, CategoryInflammatory Disease
Tags , ,
Wednesday
Nov242010

NCT01250470

Survivin Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Phase I Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH (SurVaxM) in Patients with Survivin-Positive Malignant Gliomas

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Tumor
Sponsors: Roswell Park Cancer Institute
Collaborators: NCI, MimiVax
Phase I

Date: DateNovember 24, 2010
Categories CategoryCancer - Brain & CNS
Tags , ,
Monday
Nov222010

NCT01248273

Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

Conditions: Fallopian Tubes, Ovarian Cancer, Peritoneal Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I

Date: DateNovember 22, 2010
Categories CategoryCancer - Female Reproductive, CategoryCancer - Peritoneal
Tags , , , , , , ,
Friday
Nov192010

NCT01245673  

Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma

Conditions: Multiple Myeloma
Sponsors: Abramson Cancer Center of the University of Pennsylvania
Phase: II 

Date: DateNovember 19, 2010
Categories CategoryCancer - Myeloma
Tags ,
Thursday
Oct142010

NCT01223235

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

Conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, Genentech
Phase n/a 

Date: DateOctober 14, 2010
Categories CategoryCancer - Female Reproductive, CategoryCancer - Peritoneal
Tags , ,
Wednesday
Aug252010

NCT01189383

IL15 Dendritic Cell Vaccine for Patients With Resected Stage IIIc and Stage IV Melanoma

Conditions: Stage IIIc/IV Melanoma
Sponsors: Baylor Research Institute
Phase I, II

Date: DateAugust 25, 2010
Categories CategoryCancer - Melanoma
Tags , , ,
Friday
Jul302010

NCT01174082

Donor Lymphocyte Infusion for Myeloma

Conditions: Myeloma
Sponsors: M.D. Anderson Cancer Center
Phase 2

Date: DateJuly 30, 2010
Categories CategoryCancer - Myeloma
Tags , , ,
Tuesday
Jul272010

NCT01171729

Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

Conditions: Prostatic Cancer
Sponsors: Samsung Medical Center
Phase I, II

Date: DateJuly 27, 2010
Categories CategoryCancer - Prostate
Tags ,
Page 1 ... 3 4 5 6 7 ... 16 Next 10 Entries »